AAAAAA
Results:
1-10
|
Results: 10
Authors:
Antonaci, S
Piazzolla, G
Napoli, N
Vella, FS
Fiore, G
Schiraldi, O
Citation: S. Antonaci et al., Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in chronic hepatitis C: a critical reappraisal, MICROBIOS, 106(415), 2001, pp. 203-212
Authors:
Sacco, R
Leuci, D
Tortorella, C
Fiore, G
Marinosci, F
Schiraldi, O
Antonaci, S
Citation: R. Sacco et al., Transforming Growth Factor beta 1 and soluble Fas serum levels in hepatocellular carcinoma, CYTOKINE, 12(6), 2000, pp. 811-814
Authors:
De Mitrio, V
Marino, R
Cicinelli, E
Galantino, P
Di Bari, L
Giannoccaro, F
De Pergola, G
Lapecorella, M
Schonauer, S
Schiraldi, O
Citation: V. De Mitrio et al., Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C, BL COAG FIB, 11(2), 2000, pp. 175-182
Authors:
Tortorella, C
Sacco, R
Orlando, P
Salerno, MT
Schiraldi, O
Antonaci, S
Citation: C. Tortorella et al., sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology, IMMUNOPH IM, 22(1), 2000, pp. 19-33
Authors:
Piazzolla, G
Tortorella, C
Schiraldi, O
Antonaci, S
Citation: G. Piazzolla et al., Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha, J CLIN IMM, 20(1), 2000, pp. 54-61
Authors:
De Mitrio, V
Marino, R
Scaraggi, FA
Di Bari, L
Giannoccaro, F
Petronelli, M
Ranieri, P
Tannoia, N
Schiraldi, O
Citation: V. De Mitrio et al., Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation, BL COAG FIB, 10(7), 1999, pp. 409-416
Authors:
De Mitrio, V
Marino, R
Rendina, M
Di Bari, L
Francavilla, A
Schiraldi, O
Citation: V. De Mitrio et al., Is activated protein C resistance following orthotopic liver transplantation a risk factor for venous thrombosis?, BL COAG FIB, 10(4), 1999, pp. 211-212
Authors:
Scaraggi, FA
De Mitrio, V
Marino, R
Speciale, V
Di Bari, L
Petronelli, M
Schiraldi, O
Citation: Fa. Scaraggi et al., Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections, BL COAG FIB, 10(1), 1999, pp. 33-38
Authors:
Antonaci, S
Jirillo, E
Schiraldi, O
Citation: S. Antonaci et al., Soluble HLA class I antigens in chronic hepatitis C: A disease-associated manifestation or molecules modulating immunoresponsiveness?, IMMUNOPH IM, 21(4), 1999, pp. 727-738
Authors:
Fiore, G
Piazzolla, G
Galetta, V
Caccetta, L
Schiraldi, O
Antonaci, S
Citation: G. Fiore et al., Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activities, MICROBIOS, 97(386), 1999, pp. 29-38
Risultati:
1-10
|